Chief Technology Officer
M
Mediark
This biopharmaceutical delivery platform creates customized porous biomaterials and pharmaceutical particles by designing metal combinations optimized for immune activity and cell regeneration. These materials can be used in applications such as adsorption, catalysis, drug delivery, and pharmaceutical development.
- Biotechnology
- Chemical Technology
Updated 21 months ago
Funding
Raised to date
$2.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for delivering biopharmaceuticals and developing chemical materials often lack precise control over material properties, limiting their effectiveness in targeted drug delivery, catalysis, and other advanced applications. Traditional materials may not be optimized for specific immune responses or cellular regeneration processes.
Solution
Mediark provides a customizable biopharmaceutical delivery platform that designs porous biomaterials and pharmaceutical particles with optimized metal combinations. Mediark leverages Metal-Organic Frameworks (MOFs), Zeolitic Imidazole Frameworks (ZIFs), and Covalent Organic Frameworks (COFs) to create materials with tailored pore size, surface modification, and particle size. These materials are designed to enhance immune activity and cell regeneration, enabling applications in drug delivery, vaccine development, and chemical catalysis. Mediark's technology facilitates the development of targeted therapies and advanced materials by precisely controlling material characteristics at the nano and micro levels.
Target Audience
Mediark's primary customers include pharmaceutical companies, biotechnology firms, and research institutions focused on drug delivery, vaccine development, and advanced material science.
Features
- Designs Metal-Organic Frameworks (MOFs), Zeolitic Imidazole Frameworks (ZIFs), and Covalent Organic Frameworks (COFs)
- Offers control over pore size, surface modification, and particle size
- Develops materials optimized for immune activity and cell regeneration
- Creates customized materials for specific applications through tailored metal combinations
- Provides materials suitable for gas adsorption, catalysis, and sensing
- Develops drug delivery carriers for mRNA, DNA, and other therapeutics
- Focuses on developing materials for vaccines, antibody therapeutics, and synthetic drugs